Caplight Directory>Companies>Model Medicines-preview>Modelmedicines


Model Medicines

Model Medicines

Private
La Jolla, CaliforniaHealthcare & Life Scienceshttps://modelmedicines.com

Last Round

Seed

Nov 14, 2025

Total Funding Raised

$4.1M

Company Overview

Model Medicines is a biotechnology company that has developed an AI-driven drug discovery platform to accelerate the creation of therapeutics for areas including oncology, virology, and neurological disorders.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Application

Keywords

AI drug discoveryin-silico discoverytechbiocomputational drug discoveryAI drug discovery platformdrug development pipelinegenerative chemistrypreclinical developmentbiotech partnershipsdrug licensinglead optimizationmedicinal chemistryinfectious disease therapeuticsoncology drug discoverymedical countermeasuresBARDA

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Model Medicines Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Model Medicines Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedNov 14, 2025
AcceleratorJun 10, 2025
Series ANov 3, 2021
View all Funding Rounds

Key People

Founding team and executive leadership

Sean Russell

Co-founder, Chief Operating Officer And Head Of Discovery, Research And Development

Founding Team

Daniel Haders

Chief Executive Officer, Co-Founder, Board Director, Executive Chairman

Founding Team

Model Medicines Investors

Notable investors and investment history

InvestorRounds
Nex CubedSeries A
Irving InvestorsSeries A
8VCSeries A
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 24, 2026

    Monthly visitors increased 40% MoM.

  • Mar 19, 2026

    CEO to present at the Artificial Intelligence Convergence Summit in Boston.

View all signals

Model Medicines Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Model Medicines Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Model Medicines's valuation, stock price, and market status.

Firmographic Details

HeadquartersLa Jolla, California
Employee Range14
Year Founded2019
Last FundingNov 14, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.